Ostatní
Návod 
Fulgent Genetics, Inc.
FLGT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.8B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-4%
ROA
-4%
PE
-8
PS
1
Cena 1R
15-31
⌀ Cena
22.36
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
27-02-2026
Poslední dividenda
Profil
Společnost Fulgent Genetics, Inc. spolu se svými dceřinými společnostmi poskytuje lékařům a pacientům ve Spojených státech i mezinárodně služby v oblasti COVID-19, molekulární diagnostiky a genetického testování. Společnost nabízí genetické testy zahrnující testy Focus a Comprehensive oncology panels; testy Beacon carrier screening panels pro dědičné stavy; molekulární profilování solidních nádorů pro testování somatických nádorů; rychlé testování celého genomu pro děti v NICU a PICU; nově narozený panel pro genetickou analýzu; jednořádkový test pro detekci variant souvisejících s ataxií a opakované expanze pomocí sekvenování; obrázková genetika, genetické testy iniciované pacientem; testy celých exomů a klinických exomových panelů; služby testování celého genomu, mutace a opakovaných expanzí, jakož i testy výzkumných služeb. Poskytuje také sekvenční a reverzní transkripční polymerázové řetězové reakční testy příští generace, stejně jako antigenové diagnostické testy pro detekci SARS-CoV-2. Kromě toho společnost nabízí průtokovou cytometrii, techniku buněčné analýzy, která poskytuje diagnostiku, prognózu a sledování malignit; fluorescenční in-situ hybridizaci pro detekci a lokalizaci specifické sekvence DNA na chromozomu; imunohistochemii, zobrazovací techniku používanou k vizualizaci antigenů v buňkách; cytogenetiku, která analyzuje chromozomy nastavené pro numerické a strukturální abnormality; a molekulární testování, které zahrnuje hematopoetické a molekulární testy pevných tumorů. Společnost poskytuje služby pojišťovnám, nemocnicím, lékařským institucím, dalším laboratořím, vládním orgánům, plátcům, obcím a velkým korporacím a pacientům. Společnost Fulgent Genetics má strategické partnerství se společností Helio Health, Inc. za účelem komercializace raných testů na detekci rakoviny založených na krvi. Společnost byla dříve známá jako Fulgent Diagnostics, Inc. a v srpnu 2016 změnila svůj název na Fulgent Genetics, Inc. Společnost Fulgent Genetics, Inc. byla založena v roce 2011 a sídlí v kalifornském Temple City.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
1313
Založení
2016-09-29
Podobné společnosti
$ 6.46
+ $ 0.16
$ 16.17
+ $ 0.55
$ 2.20
- $ 0.04
$ 11.24
+ $ 0.61
$ 8.71
- $ 0.02
$ 6.51
- $ 0.78
$ 1.77
+ $ 0.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 322.7 | 322.7 | 283.5 | 289.2 | 619.0 | 992.6 | 421.7 | 32.5 | 21.4 | 18.7 | 18.3 | 9.6 | 1.3 | |
| Cost of Revenues | 191.8 | 191.8 | 176.3 | 184.8 | 252.1 | 215.5 | 89.8 | 14.1 | 10.7 | 8.6 | 6.7 | 5.1 | 0.9 | |
| Gross Profit | 130.9 | 130.9 | 107.2 | 104.5 | 366.9 | 777.1 | 331.9 | 18.4 | 10.7 | 10.2 | 11.6 | 4.5 | 0.3 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 83.3 | 84.1 | 81.8 | 73.5 | 76.2 | 71.7 | 71.0 | 64.5 | 70.5 | 84.7 | |
| Cost of Revenues | 50.8 | 48.6 | 47.4 | 45.1 | 44.4 | 45.0 | 44.5 | 42.4 | 47.2 | 44.8 | |
| Gross Profit | 32.6 | 35.5 | 34.4 | 28.3 | 31.8 | 26.8 | 26.5 | 22.1 | 23.3 | 39.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 41.4 | 28.9 | 24.2 | 11.6 | 6.5 | 5.5 | 4.2 | 3.6 | 4.4 | 0.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 130.5 | 150.0 | 75.2 | 30.2 | 12.3 | 10.2 | 9.4 | 7.1 | 5.1 | 0.8 | |
| Depreciation & Amortization | 24.1 | 24.1 | 24.9 | 26.1 | 12.4 | 1.7 | 3.0 | 2.1 | 2.2 | 1.7 | 1.2 | 0.6 | 0.2 | |
| Total Operating Expenses | 222.0 | 222.0 | 181.1 | 171.9 | 185.4 | 101.1 | 41.7 | 18.8 | 15.7 | 13.6 | 10.6 | 9.5 | 1.3 | |
| Operating Income | -91.1 | -91.1 | -73.9 | -72.7 | 178.5 | 676.0 | 290.2 | -0.4 | -5.1 | -3.4 | 0.9 | -5.0 | -1.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.0 | 10.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 42.2 | 27.7 | ||
| Depreciation & Amortization | 6.1 | 6.0 | 6.1 | 5.9 | 6.2 | 5.9 | 6.2 | 6.7 | 6.5 | 5.1 | ||
| Total Operating Expenses | 68.8 | 50.9 | 54.1 | 48.1 | 48.0 | 43.9 | 45.4 | 43.9 | 54.2 | 39.6 | ||
| Operating Income | -36.2 | -15.4 | -19.7 | -19.8 | -16.1 | -17.1 | -18.9 | -21.8 | -30.9 | 0.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 30.9 | 30.9 | 31.3 | 21.4 | 5.5 | 1.3 | 1.5 | 0.8 | 0.4 | 0.5 | -5.4 | 0.0 | 0.0 | |
| Interest Expense | 0.2 | 0.1 | 0.2 | 0.0 | 5.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | 0.0 | 0.0 | |
| Other Expense | 22.4 | 21.1 | 22.0 | -101.4 | 5.5 | 1.3 | 1.5 | 0.8 | 0.4 | 0.5 | -5.4 | 0.0 | 0.0 | |
| IBT | -68.7 | -70.0 | -52.0 | -174.1 | 184.0 | 677.3 | 291.7 | 0.4 | -4.6 | -2.9 | -4.5 | -5.0 | -1.0 | |
| Income Tax Expense | -7.0 | -8.4 | -8.1 | 1.2 | 42.1 | 174.8 | 72.5 | 0.0 | -1.1 | -0.8 | 0.9 | 3.3 | 3.3 | |
| Net Income | -60.5 | -60.5 | -42.7 | -167.8 | 143.4 | 507.4 | 214.3 | 0.4 | -4.5 | -2.7 | -5.4 | -8.3 | -4.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.9 | 7.9 | 8.1 | 8.0 | 8.3 | 8.1 | 7.7 | 7.6 | 5.9 | 6.6 | ||
| Interest Expense | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 36.5 | 0.1 | ||
| Other Expense | 7.0 | 9.2 | -1.8 | 8.1 | 8.1 | -1.5 | 7.7 | 7.6 | -111.7 | 6.6 | ||
| IBT | -29.3 | -6.1 | -21.5 | -11.7 | -8.0 | -18.5 | -11.2 | -14.2 | -145.2 | 6.9 | ||
| Income Tax Expense | -5.6 | 0.7 | -2.3 | 0.2 | -1.9 | -3.8 | -2.1 | -0.3 | -10.9 | 20.3 | ||
| Net Income | -23.4 | -6.6 | -19.0 | -11.5 | -5.9 | -14.6 | -8.7 | -13.5 | -128.1 | -13.1 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-5.63 | $4.76 | $17.25 | $9.44 | $0.02 | $-0.25 | $-0.15 | $-0.30 | $-0.65 | $-0.34 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-5.63 | $4.63 | $16.38 | $8.91 | $0.02 | $-0.25 | $-0.15 | $-0.30 | $-0.65 | $-0.34 | |
| Shares Outstanding | 30.8 | 30.8 | 30.2 | 29.8 | 30.1 | 29.4 | 22.7 | 18.7 | 18.0 | 17.7 | 17.7 | 12.8 | 12.8 | |
| Diluted Shares Outstanding | 30.8 | 30.8 | 30.2 | 29.8 | 31.0 | 31.0 | 24.1 | 18.7 | 18.0 | 17.7 | 17.7 | 12.8 | 12.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-4.30 | $-0.44 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-4.30 | $-0.44 | ||
| Shares Outstanding | 30.8 | 30.7 | 30.8 | 30.8 | 30.7 | 30.4 | 30.1 | 29.8 | 29.8 | 30.0 | ||
| Diluted Shares Outstanding | 30.8 | 30.7 | 30.8 | 30.8 | 30.7 | 30.4 | 30.1 | 29.8 | 29.8 | 30.0 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 65.1 | 55.1 | 97.5 | 79.5 | 164.9 | 87.4 | 12.0 | 6.7 | 6.5 | 7.9 | 0.5 | 0.2 | |
| Short Term Investments | 246.6 | 203.0 | 326.7 | 773.4 | 770.7 | 344.4 | 58.3 | 30.7 | 34.9 | 38.6 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 311.7 | 258.1 | 424.2 | 852.9 | 935.5 | 431.9 | 70.2 | 37.4 | 41.4 | 46.5 | 0.5 | 0.2 | |
| Accounts Receivable | 63.7 | 77.0 | 57.4 | 52.7 | 138.9 | 183.9 | 6.6 | 6.0 | 4.0 | 4.4 | 2.2 | 0.4 | |
| Inventory | 7.0 | 8.4 | 0.0 | 4.3 | 12.2 | 16.5 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 | 0.1 | |
| Other Current Assets | 23.7 | 10.1 | 26.2 | 22.2 | -12.2 | -16.5 | 0.3 | 0.3 | 2.4 | 0.3 | 0.2 | 0.1 | |
| Total Current Assets | 399.1 | 353.6 | 507.8 | 905.6 | 1,074.5 | 615.7 | 76.8 | 43.4 | 45.4 | 50.8 | 2.9 | 0.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 117.6 | 87.9 | 67.3 | 55.1 | 58.0 | 65.1 | 54.7 | 97.5 | 84.1 | 58.3 | |
| Short Term Investments | 258.2 | 205.0 | 253.0 | 203.0 | 155.0 | 246.6 | 251.0 | 326.7 | 383.7 | 400.1 | |
| Total Cash & ST Investments | 375.8 | 292.9 | 320.3 | 258.1 | 213.1 | 311.7 | 305.7 | 424.2 | 467.8 | 458.4 | |
| Accounts Receivable | 78.7 | 85.0 | 80.4 | 77.0 | 57.3 | 63.7 | 59.4 | 57.4 | 54.6 | 39.7 | |
| Inventory | 10.1 | 9.0 | 8.6 | 8.4 | 8.6 | 7.0 | 6.5 | 5.8 | 4.9 | 5.5 | |
| Other Current Assets | 42.8 | 41.8 | 7.4 | 10.1 | 47.5 | 16.7 | 14.9 | 20.4 | 22.5 | 24.6 | |
| Total Current Assets | 507.4 | 428.7 | 416.8 | 353.6 | 326.5 | 399.1 | 386.5 | 507.8 | 549.9 | 528.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 102.6 | 105.5 | 95.6 | 81.4 | 62.3 | 40.2 | 6.0 | 6.4 | 7.3 | 6.2 | 2.5 | 1.0 | |
| Goodwill | 22.1 | 22.1 | 22.1 | 143.0 | 50.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 139.0 | 135.0 | 143.1 | 150.6 | 35.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 546.6 | 570.4 | 444.0 | 339.0 | 507.0 | 132.5 | 42.8 | 7.9 | 16.8 | 25.6 | 0.0 | 0.0 | |
| Other Long-Term Assets | 23.0 | 33.5 | 22.7 | -233.6 | 142.0 | -88.0 | -36.8 | -2.7 | 4.3 | 1.0 | 0.4 | 0.4 | |
| Total Long-Term Assets | 833.1 | 866.4 | 727.5 | 480.4 | 204.3 | 84.7 | 12.0 | 11.6 | 11.6 | 7.2 | 2.9 | 1.4 | |
| Total Assets | 1,232.2 | 1,220.0 | 1,235.3 | 1,386.1 | 1,278.7 | 700.5 | 88.8 | 55.0 | 57.0 | 58.0 | 5.8 | 2.1 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 111.9 | 110.2 | 107.1 | 105.5 | 106.8 | 93.4 | 86.7 | 94.3 | 85.3 | 87.6 | |
| Goodwill | 25.1 | 22.1 | 22.1 | 22.1 | 22.1 | 22.1 | 22.1 | 22.1 | 141.8 | 142.0 | |
| Intangible Assets | 135.3 | 131.1 | 133.0 | 135.0 | 137.1 | 139.0 | 141.0 | 143.1 | 144.5 | 146.5 | |
| Long-Term Investments | 411.8 | 484.5 | 494.1 | 570.4 | 602.2 | 546.6 | 560.9 | 444.0 | 398.8 | 401.2 | |
| Other Long-Term Assets | 23.2 | 23.3 | 32.7 | 33.5 | 39.0 | 32.1 | 32.7 | 32.0 | 38.1 | 49.1 | |
| Total Long-Term Assets | 707.2 | 771.1 | 789.0 | 866.4 | 907.2 | 833.1 | 843.4 | 765.3 | 808.5 | 826.3 | |
| Total Assets | 1,214.6 | 1,199.8 | 1,205.7 | 1,220.0 | 1,233.8 | 1,232.2 | 1,229.9 | 1,273.1 | 1,358.4 | 1,354.6 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 19.9 | 18.4 | 15.4 | 23.1 | 20.5 | 26.5 | 1.6 | 1.3 | 2.1 | 2.8 | 0.3 | 0.2 | |
| Short-Term Debt | 3.2 | 1.9 | 5.1 | 20.6 | 21.3 | 15.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 49.9 | 22.8 | 26.9 | 58.4 | 36.7 | 62.7 | 3.6 | 1.4 | 0.8 | 0.8 | 0.4 | 0.3 | |
| Current Liabilities | 75.8 | 72.9 | 73.0 | 116.2 | 112.8 | 131.1 | 6.0 | 2.7 | 2.9 | 3.6 | 0.7 | 0.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.1 | 18.9 | 18.2 | 18.4 | 19.8 | 19.9 | 19.6 | 15.4 | 15.8 | 20.6 | |
| Short-Term Debt | 2.0 | 1.7 | 1.8 | 1.9 | 0.4 | 2.7 | 3.3 | 5.1 | 2.9 | 4.6 | |
| Other Current Liabilities | 21.5 | 20.5 | 15.4 | 22.8 | 26.8 | 24.1 | 23.0 | 26.9 | 21.3 | 22.6 | |
| Current Liabilities | 72.4 | 71.3 | 65.9 | 72.9 | 74.0 | 75.8 | 75.9 | 73.0 | 61.4 | 64.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2.5 | 6.6 | 10.1 | 0.0 | 0.0 | 0.6 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 7.7 | 5.6 | 11.1 | 0.0 | 0.0 | 0.8 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 13.2 | 6.4 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | |
| Total Liabilities | 103.4 | 90.8 | 102.0 | 116.2 | 112.8 | 131.1 | 6.0 | 2.7 | 2.9 | 3.6 | 0.7 | 0.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 5.6 | 5.7 | 5.9 | 6.6 | 0.0 | 9.6 | 9.1 | 10.1 | 0.0 | 0.0 | |
| Capital Leases | 5.1 | 5.0 | 5.2 | 5.6 | 6.1 | 9.4 | 9.5 | 9.2 | 10.0 | 11.0 | |
| Def. Tax Liability | 7.0 | 6.1 | 6.2 | 6.4 | 6.7 | 6.9 | 7.4 | 51.7 | 9.8 | 9.8 | |
| Total Liabilities | 93.8 | 88.2 | 83.0 | 90.8 | 98.9 | 103.4 | 103.2 | 139.8 | 96.6 | 91.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.3 | 0.0 | |
| Retained Earnings | 611.0 | 590.5 | 633.2 | 801.0 | 657.6 | 150.9 | -63.4 | -63.0 | -57.7 | -55.2 | -53.2 | -10.3 | |
| Comprehensive Income | -0.9 | -0.4 | 1.2 | -20.9 | -0.8 | 0.4 | 0.1 | 0.0 | 0.0 | -0.1 | -0.9 | -0.4 | |
| Total Common Equity | 1,132.5 | 1,133.2 | 1,136.1 | 1,269.9 | 1,165.9 | 569.4 | 82.8 | 52.3 | 54.0 | 54.5 | 5.1 | 1.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 553.4 | 560.0 | 578.9 | 590.5 | 596.4 | 611.0 | 619.7 | 633.2 | 761.3 | 774.4 | |
| Comprehensive Income | 6.8 | 6.0 | 4.3 | -0.4 | 9.2 | -0.9 | -1.1 | 1.2 | -16.9 | -20.7 | |
| Total Common Equity | 1,125.9 | 1,116.6 | 1,127.2 | 1,133.2 | 1,138.4 | 1,132.5 | 1,129.9 | 1,136.1 | 1,258.7 | 1,259.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 13.4 | 8.5 | 15.3 | 20.6 | 21.3 | 15.9 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,128.8 | 1,129.2 | 1,133.3 | 1,269.9 | 1,165.9 | 569.4 | 82.8 | 52.3 | 54.0 | 54.5 | 5.1 | 1.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | -5.1 | -4.9 | -4.4 | -4.1 | -3.5 | -3.7 | -3.3 | -2.8 | 3.1 | 3.6 | |
| Book Value | 1,125.9 | 1,116.6 | 1,127.2 | 1,133.2 | 1,138.4 | 1,132.5 | 1,129.9 | 1,136.1 | 1,258.7 | 1,259.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -163.8 | -61.6 | -43.8 | -167.8 | 141.9 | 506.2 | 214.3 | -0.4 | -5.6 | -2.5 | -5.4 | -5.0 | -1.0 | |
| Depreciation & Amortization | 25.8 | 24.1 | 24.9 | 31.8 | 32.7 | 11.0 | 3.0 | 2.1 | 2.2 | 1.7 | 1.2 | 0.6 | 0.2 | |
| Stock-Based Compensation | 45.5 | 39.6 | 44.5 | 42.9 | 32.6 | 15.9 | 8.2 | 3.2 | 2.3 | 2.1 | 4.7 | 8.2 | 0.0 | |
| Change Working Capital | 1.4 | -117.6 | -7.2 | 2.8 | 2.0 | -2.7 | -91.5 | -0.9 | -1.2 | -0.7 | -1.9 | -1.7 | -0.3 | |
| Change In Accounts Receivable | -18.7 | -23.3 | -16.3 | 2.4 | 68.6 | 42.3 | -178.5 | -0.8 | -2.0 | 0.2 | -2.3 | -1.8 | -0.4 | |
| Change In Accounts Payable | -0.9 | 0.6 | 3.1 | -6.9 | -25.3 | -12.2 | 22.6 | -0.3 | 0.1 | -0.4 | 1.1 | 0.1 | 0.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -36.2 | -30.5 | -23.5 | -2.3 | -0.3 | |
| Other Non-cash Items | 157.9 | 15.1 | 7.9 | 109.7 | 43.5 | 16.0 | 8.0 | 1.5 | 1.7 | 1.0 | 5.6 | 0.4 | -3.3 | |
| Cash from Operations | 36.7 | 0.0 | 0.0 | 27.0 | 253.5 | 538.6 | 140.6 | 5.5 | -0.7 | 1.3 | 4.4 | -1.0 | -4.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -23.7 | -6.8 | -19.3 | -11.9 | -6.2 | -14.7 | -9.1 | -13.8 | -128.1 | -13.5 | |
| Depreciation & Amortization | 6.1 | 6.0 | 6.1 | 5.9 | 6.2 | 5.9 | 6.2 | 6.7 | 6.5 | 6.4 | |
| Stock-Based Compensation | 9.3 | 9.7 | 10.0 | 10.6 | 10.4 | 10.9 | 11.6 | 11.5 | 11.4 | 10.9 | |
| Change Working Capital | -71.7 | 2.4 | -38.5 | -9.8 | 16.2 | -25.8 | -2.6 | 4.9 | 10.2 | -11.2 | |
| Change In Accounts Receivable | -15.4 | 4.9 | -8.3 | -4.5 | -13.3 | -1.6 | -2.9 | 1.5 | -5.2 | -12.1 | |
| Change In Accounts Payable | 0.9 | -0.1 | 0.4 | -0.7 | -0.8 | 2.3 | 1.8 | -0.2 | 0.1 | -2.6 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 2.4 | 0.5 | 11.5 | 0.8 | 0.5 | 10.4 | -1.7 | -1.4 | 114.4 | -1.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.9 | 10.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -25.0 | -22.6 | -40.3 | -22.2 | -18.8 | -23.8 | -36.5 | -1.3 | -2.8 | -5.4 | -3.8 | -2.1 | -0.7 | |
| Acquisitions | 0.2 | 3.8 | 0.0 | -0.4 | -182.7 | -61.9 | -2.6 | 0.1 | 0.5 | 2.5 | 0.0 | 0.0 | 0.0 | |
| Investments | -500.2 | -80.8 | -472.4 | -491.9 | -433.0 | -730.5 | -324.4 | -52.1 | -24.2 | -11.7 | -39.0 | 0.0 | 0.0 | |
| Sales of Investment | 529.5 | 211.0 | 454.1 | 552.6 | 372.7 | 269.6 | 37.0 | 24.4 | 28.0 | 15.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 73.3 | 0.0 | 0.0 | 0.8 | 0.4 | 0.1 | 0.0 | -0.1 | -0.5 | -2.5 | 0.0 | -0.1 | 0.0 | |
| Cash from Investing | 4.5 | 0.0 | 0.0 | 38.9 | -261.3 | -546.5 | -326.4 | -29.0 | 1.0 | -2.0 | -42.8 | -2.2 | -0.8 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -5.0 | -6.1 | -6.8 | -4.7 | -3.8 | -19.5 | -12.9 | -4.1 | -3.1 | -4.9 | |
| Acquisitions | 3.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Investments | -62.0 | -18.9 | 0.0 | 0.0 | -98.2 | -115.4 | -63.1 | -195.7 | -148.3 | -93.1 | |
| Sales of Investment | 78.1 | 40.2 | 60.2 | 32.4 | 74.5 | 143.9 | 83.3 | 152.4 | 175.8 | 118.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 27.8 | 25.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.3 | 20.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -27.2 | 0.0 | 0.0 | -5.0 | -1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -27.0 | 0.0 | 0.0 | |
| Debt Issued | 36.0 | 8.5 | -6.8 | -0.4 | 0.4 | 5.4 | 13.2 | 2.7 | 0.0 | 0.0 | 27.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 89.5 | 246.2 | 28.8 | 0.0 | 0.0 | 36.8 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -27.5 | -10.9 | -3.1 | -27.8 | -74.3 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | -12.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.8 | 0.0 | 0.0 | |
| Other Financing Activities | -1.4 | 0.0 | 0.0 | -17.7 | -1.8 | -4.1 | 15.1 | 0.0 | 0.0 | -0.8 | 52.7 | 3.5 | 4.0 | |
| Cash from Financing | -34.4 | 0.0 | 0.0 | -47.8 | -77.1 | 85.4 | 261.3 | 28.8 | 0.0 | -0.8 | 45.8 | 3.5 | 4.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.0 | -1.8 | |
| Debt Issued | 7.5 | 0.2 | -0.3 | -0.8 | 8.1 | -11.9 | 0.0 | -2.5 | 25.0 | 0.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.4 | -0.4 | -2.6 | -10.6 | -0.2 | -0.4 | -0.5 | -1.9 | -24.0 | -2.7 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -26.0 | -4.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 6.8 | -5.0 | -42.2 | 18.0 | -85.4 | 77.5 | 75.5 | 5.2 | 0.2 | -1.4 | 7.4 | 0.3 | -1.2 | |
| Closing Cash Balance | 65.1 | 50.3 | 55.3 | 97.5 | 79.5 | 164.9 | 87.4 | 12.0 | 6.7 | 6.5 | 7.9 | 0.5 | 0.2 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -67.4 | 29.8 | 20.6 | 12.1 | -2.9 | -6.9 | 10.4 | -42.8 | 13.4 | 25.7 | |
| Closing Cash Balance | 50.3 | 117.8 | 88.0 | 67.4 | 55.3 | 58.2 | 65.1 | 54.7 | 97.5 | 84.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 11.7 | -124.2 | -19.3 | 4.8 | 234.7 | 514.7 | 104.1 | 4.2 | -3.5 | -4.0 | 0.6 | -3.1 | -5.1 | |
| Real Free Cash Flow | -33.8 | -163.8 | -63.7 | -38.1 | 202.1 | 498.9 | 96.0 | 1.0 | -5.8 | -6.1 | -4.0 | -11.2 | -5.1 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -83.1 | 5.1 | -37.0 | -9.1 | 21.2 | -35.0 | -8.7 | 3.2 | 11.8 | 5.3 | |
| Real Free Cash Flow | -92.4 | -4.7 | -47.0 | -19.7 | 10.8 | -46.0 | -20.3 | -8.3 | 0.4 | -5.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -7.9 | -505.4 | 63 |
| P/S | 1.5 | 4.6 | 57.8 |
| P/B | 0.4 | 2.3 | 29.8 |
| P/FCF | -2.9 | 38.1 | 549.4 |
| Market cap | $0.8 | $0.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0.6 % | 1.2 % | 0 % |
| Debt to Income | -12.5 % | -40.5 % | 0 % |
| Debt to Free cash flow | -4.6 % | -187.8 % | 0 % |
| Interest expense percentage | -0.2 % | 101.3 % | 2.9 % |
| Current ratio | 7 | 8.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -5.4 % | -2.5 % | 0 % |
| ROA | -5 % | -2.2 % | 0 % |
| CapEx to Revenue | 6.8 % | 12.4 % | 0 % |
| RaD to Revenue | 0 % | 17.6 % | 0 % |
| ROEM | 322,671.0 | 372068.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 41.2 % | 54.7 % | 47.8 % |
| Operating margin | -22.5 % | -0.9 % | 28 % |
| Net margin | -13.6 % | -12.4 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.4 % | 0 % |
| Dividend payout percentage | 0 % | -625.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 30.7 mil | 23.9 mil |
| Employee count | 1.0 tis | 0.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
